Pharmacokinetics and organ distribution of intravenous and oral methylene blue (2000)

Peer-Reviewed Study · Peter C, Hongwan D, Küpfer A, Lauterburg BH · June 2000

Peter C et al., 2000-06: The basic human pharmacokinetic study: seven healthy volunteers given 100 mg methylene blue intravenously and orally, with a terminal half-life of about 5.25 hours and rat tissue-distribution data showing hepatic handling.

The concentration of methylene blue in whole blood was measured using high-performance liquid chromatography in seven volunteers after i.v. and oral administration of 100 mg methylene blue with and without mesna.

Peter C et al., 2000-06: The basic human pharmacokinetic study: seven healthy volunteers given 100 mg methylene blue intravenously and orally, with a terminal half-life of about 5.25 hours and rat tissue-distribution data showing hepatic handling. C7 background PK (healthy volunteers only – no impaired patients). Dose/route: 100 mg IV and 100 mg oral, with and without mesna. Funder/conflicts not stated in abstract. Comparator: IV vs oral. Note the half-life here (5.25 h) differs sharply from the current label's "approximately 24 hours" and from the 38 h calculated in the overdose case (Chan 2018) – the three figures are recorded as published and not reconciled. Also filed as MTC-086, MTK-44, MTB-11, MTJ-24, MTR-010, MTB-41, MTF-18, MTF-08 (claims C1, C14, C4, C5, C7, C9, F1).